Carleton University
Examining the impact of poly- and perfluoroalkyl substances (PFAS) exposure on metabolic health
Abstract
dc:description.abstractPoly- and perfluoroalkyl substances (PFAS) are a class of synthetic chemicals widely used in consumer and industrial products. PFAS are linked to numerous adverse health effects, including Type 2 diabetes (T2D). Epidemiological evidence suggests PFAS may impair metabolic adaptation during periods of increased physiological demand, such as pregnancy; however, few studies have investigated the effects of PFAS exposure on subclinical markers of metabolic health. In addition, while experimental evidence suggests that PFAS exposure may dysregulate insulin secretion in immortalized beta cell lines, no studies have investigated the effects on islet function in primary models. In this thesis, we used epidemiological and experimental approaches. Our epidemiological approach (Chapters 2-4) leveraged data from the Maternal-Infant Research on Environmental Chemicals (MIREC) study, a pan-Canadian longitudinal pregnancy study. We evaluated associations between prenatal legacy PFAS concentrations and markers of metabolic dysfunction measured during pregnancy and at 7-9 years follow-up. We also evaluated concurrently measured legacy and replacement PFAS and markers of beta cell function and glucose homeostasis at 7-9 years follow-up. We found prenatal PFAS concentrations were positively associated with inflammatory biomarkers, including a derived proinflammatory index measured during pregnancy, and markers of insulin resistance and beta cell dysfunction at 7-9 years follow-up. Our cross-sectional analysis showed that legacy PFAS were associated with beta cell dysfunction and decreased insulin resistance. Findings relevant to replacement PFAS and outcome measures were of smaller magnitude and less precise. In Chapter 5, we evaluated the biodistribution of legacy PFAS in mouse and human pancreas tissue and showed that PFOS more readily accumulates in pancreas than PFOA. We also show that acute and prolonged PFOS exposure suppresses insulin secretion in immortalized beta cells and had variable effects on insulin secretion in primary human donor islets. Perifusion analysis revealed that PFOS acutely amplified glucose-stimulated insulin secretion in male and female mouse islets. When PFOS was co-administered with a glucagon-like peptide (GLP)-1 antagonist, Exendin9-39, the acute insulin hypersecretion was partially suppressed. This thesis provides evidence that PFAS exposure may be linked to metabolic dysfunction, the impact of which may be particularly pronounced during pregnancy and/or post-partum.
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy (Ph.D.)
- Level thesis:degree_level
- Doctoral
- Discipline thesis:degree_discipline
- Biology
- Grantor dc:publisher
- Carleton University
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Palaniyandi, Jana
Subjects
dc:subject × 2Rights
dc:rights- Statement dc:rights
-
- Copyright © 2025 the author(s). Theses may be used for non-commercial research, educational, or related academic purposes only. Such uses include personal study, distribution to students, research and scholarship. Theses may only be shared by linking to the Carleton University Institutional Repository and no part may be copied without proper attribution to the author; no part may be used for commercial purposes directly or indirectly via a for-profit platform; no adaptation or derivative works are permitted without consent from the copyright owner.
- Language dc:language.iso
- en